CD274 and neoplasm: Interestingly, Costantini and colleagues found no prognostic value for serum PD-L1 at baseline but high PD-L1 levels (>33.97 pg/mL) in on-treatment samples taken at first tumor evaluation were associated with poor response to ICI therapy and a shorter PFS and OS [12].